Onkologie Archive - IOZK

Home page
The IOZK
The IOZK immunotherapy
Specialist knowledge
Latest news
Contact us
menu Menu

Keyword archive for: Oncology

Personalized medicine in oncology

Worth knowing

Evidence-based medicine at the IOZK2023-02-01 - 09:51
Laboratories at the IOZK2023-01-10 - 09:03
Magazine of the IOZK Foundation: IOZK Consilium2021-03-31 - 09:03
Video: Patient Mrs. Ebel about her experiences with IOZK immunotherapy2020-11-13 - 11:58
Video: Patient reports on experiences with IOZK immunotherapy2020-11-13 - 11:58
Information brochure of the IOZK Foundation2020-04-29 - 09:03
Personalized medicine in oncology2019-01-29 - 10:29
The development of cancer2019-01-29 - 10:11
What does immunotherapy mean?2019-01-29 - 09:42
Nobel Prizes for immunotherapy2019-01-29 - 09:42
Curcumin in medical applications2019-01-29 - 09:42
Viruses against cancer: oncolytic virotherapy2019-01-29 - 09:25
Dendritic cells inform the immune system2019-01-29 - 09:03
Heat against cancer: Therapeutic hyperthermia2019-01-28 - 16:50

Search the IOZK Publication Archive for Authors, PMI, Keywords or Categories…

Kategorien

Kategorien

IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland

T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de

The IOZK

Philosophy
Team
Treatment center
Laboratories
Career
Arrival and overnight stay

The IOZK immunotherapy

IOZK immunotherapy
The IO-VAC® vaccine
Treatment procedure
Therapy costs
FAQ

News and international publications

The Complexity of Malignant Glioma Treatment
WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature

© 2025 IOZK Immun-Onkologisches Zentrum Köln

Imprint
Privacy policy
Cookie settings
Press

Nach oben scrollen